Search

More than 500 high school students and their teachers filled the Rockefeller Research Laboratories to learn about recent discoveries.

… Friday, April 1, 2011 Summary More than 500 high school students and their teachers filled the Rockefeller Research Laboratories to learn about recent discoveries. More than 500 people filled the Rockefeller Research Laboratories Auditorium in November 2010 for Major Trends in Modern Cancer Research.

Learn why Black women face a higher risk of death from endometrial cancer, and about a new effort led by Dr. Carol Brown at Memorial Sloan Kettering Cancer Center to close the gap.

… Friday, October 1, 2021 When Linda Collins was diagnosed with endometrial cancer in her early 60s, she wanted to find the best treatment possible. After doing her research, she felt confident she would receive the care she needed at Memorial Sloan Kettering Cancer Center. She also knew what she needed

Ralph DeBerardinis, a professor at the University of Texas Southwestern, was one of the recipients of the 2021 Paul Marks Prize for Cancer Research.

… Monday, February 28, 2022 The Paul Marks Prize for Cancer Research was created by the Boards of Memorial Sloan Kettering Cancer Center to honor the late Paul Marks , who served as President and CEO of MSK for almost 20 years, beginning in 1980. Awarded every other year since 2001, the prize recognizes

Over the last decade radiation oncologists at Memorial Sloan Kettering have refined a technique that allows ablative doses of radiation to be delivered with low risk of toxicity to inoperable primary pancreas and liver tumors near critical organs.

… Monday, October 24, 2016 Success rates of standard treatments for inoperable primary pancreas and liver tumors are poor, but a radiotherapy technique that combines classical, modern, and novel concepts is offering renewed hope of long-term survival for these patients. Stereotactic ablative radiation

New MSK research identifies new cancer-specific targets for T cell receptor immunotherapy approaches; sheds light on a critical process in sexual reproduction; describes how regulatory T cells help prevent intestinal inflammation; and uncovers how the spleen helps natural killer immune cells adapt to new threats.

… Monday, March 3, 2025 New research from Memorial Sloan Kettering Cancer Center (MSK) identifies new cancer-specific targets for T cell receptor immunotherapy approaches; sheds light on a critical process in sexual reproduction; describes how regulatory T cells help prevent intestinal inflammation; and

New MSK research investigates how pancreatic cancer cells regulate their genome to avoid immune attack; shows promise against glioblastoma in mouse models; and develops a new method to study cancer evolution.

… Thursday, November 21, 2024 New research from Memorial Sloan Kettering Cancer Center (MSK) investigates how pancreatic cancer cells regulate their genome to avoid immune attack; shows promise against glioblastoma in mouse models; and develops a new method to study cancer evolution. How pancreatic cancer

An innovative collaboration between basic scientists and clinical researchers has led to a promising new drug for AML.

… Monday, January 18, 2016 Summary A drug called PU-H71, developed at MSK, targets an altered version of a protein that some  acute myeloid leukemia cells need to grow. Blocking the action of this protein may be an effective way to treat these cancers. New research from MSK sheds light on which patients

Memorial Sloan Kettering is sad to note the passing on May 12 of Stephen Sternberg, at the age of 100. Dr. Sternberg spent his entire career at MSK as a surgical pathologist. Widely known as a leader in the field of pathology and highly regarded for his expertise, he was also greatly respected as an editor of major national publications, which garnered him a broad, devoted following around the world.

… Tuesday, July 27, 2021 Memorial Sloan Kettering Cancer Center is sad to note the passing on May 12, 2021, of Stephen Sternberg, at the age of 100. Dr. Sternberg spent his entire career at MSK as a surgical pathologist. Widely known as a leader in the field of pathology and highly regarded for his expertise

Moritz Kircher, MD, PhD, has been selected by the directors of the Dana Foundation as a Dana Neuroscience Scholar.

… Monday, March 5, 2012 Moritz Kircher, MD, PhD , has been selected by the directors of the Dana Foundation as a Dana Neuroscience Scholar. Dana Neuroscience Scholars are new-career investigators who have shown exceptional promise during their training and in their early research. This distinction is Dr

The reason certain patients with follicular lymphoma do worse than others may come down to a missing gene.

… Monday, July 3, 2017 Summary Follicular lymphoma is a slow-growing yet incurable form of non-Hodgkin lymphoma . New research is shedding light on the molecular causes of this type of cancer. Scientists have identified a gene that functions as a tumor suppressor. Loss or inactivation of this gene promotes